Metraipolis › archive › dc_b28932becefc

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion — Europe PMC PMID:40966072

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40966072
DOI
10.1530/etj-25-0212
License (as archived)
solo-consultazione
Archived
2026-11-09T12:11:56.022Z
SHA-256 of the archived text
7f22c7dd0e3ccb9c7f588a5de301d81b5e9682e63b4740e98948f1c04cf1b273
Stable URL of this page
https://metraipolis.com/documento/dc_b28932becefc

How to cite

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion — Europe PMC PMID:40966072 — Europe PMC (en), https://europepmc.org/article/MED/40966072 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b28932becefc (Metraipolis archive dc_b28932becefc, sha256 7f22c7dd0e3ccb9c7f588a5de301d81b5e9682e63b4740e98948f1c04cf1b273)
BibTeX
@misc{dcb28932becefc,
  title = {Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion — Europe PMC PMID:40966072},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40966072},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b28932becefc; sha256 7f22c7dd0e3ccb9c7f588a5de301d81b5e9682e63b4740e98948f1c04cf1b273},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40966072. Agents can read the archived copy with the MCP tool read_document.